JP2023524519A5 - - Google Patents
Info
- Publication number
- JP2023524519A5 JP2023524519A5 JP2022566661A JP2022566661A JP2023524519A5 JP 2023524519 A5 JP2023524519 A5 JP 2023524519A5 JP 2022566661 A JP2022566661 A JP 2022566661A JP 2022566661 A JP2022566661 A JP 2022566661A JP 2023524519 A5 JP2023524519 A5 JP 2023524519A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- formula
- hydrogen
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2006390.5 | 2020-04-30 | ||
| GBGB2006390.5A GB202006390D0 (en) | 2020-04-30 | 2020-04-30 | Novel treatments |
| PCT/EP2021/061462 WO2021219879A1 (en) | 2020-04-30 | 2021-04-30 | Treatments of inflammatory bowel disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023524519A JP2023524519A (ja) | 2023-06-12 |
| JP2023524519A5 true JP2023524519A5 (https=) | 2024-05-10 |
Family
ID=71080611
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022566660A Active JP7702427B2 (ja) | 2020-04-30 | 2021-04-30 | 炎症性腸疾患を治療するための５－クロロ－４－ヒドロキシ－１－メチル－２－オキソ－ｎ－フェニル－キノリン－３－カルボキサミドカリウム塩 |
| JP2022566661A Pending JP2023524519A (ja) | 2020-04-30 | 2021-04-30 | 炎症性腸疾患の治療 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022566660A Active JP7702427B2 (ja) | 2020-04-30 | 2021-04-30 | 炎症性腸疾患を治療するための５－クロロ－４－ヒドロキシ－１－メチル－２－オキソ－ｎ－フェニル－キノリン－３－カルボキサミドカリウム塩 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20230167064A1 (https=) |
| EP (2) | EP4142725A1 (https=) |
| JP (2) | JP7702427B2 (https=) |
| KR (2) | KR20230018386A (https=) |
| CN (2) | CN115768429B (https=) |
| AU (2) | AU2021262514A1 (https=) |
| CA (2) | CA3177000A1 (https=) |
| GB (2) | GB202006390D0 (https=) |
| WO (2) | WO2021219881A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202006390D0 (en) * | 2020-04-30 | 2020-06-17 | Aqilion Ab | Novel treatments |
| CN115836056A (zh) * | 2020-05-21 | 2023-03-21 | Stemsynergy疗法有限责任公司 | Notch抑制剂及其用途 |
| CN115120727B (zh) * | 2022-06-16 | 2024-02-23 | 甘肃农业大学 | S100a9抑制剂在制备防治c型产气荚膜梭菌感染性腹泻药物中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE52670B1 (en) * | 1981-03-03 | 1988-01-20 | Leo Ab | Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation |
| SE9400809D0 (sv) * | 1994-03-10 | 1994-03-10 | Pharmacia Ab | New use of quinoline-3-carboxamide compounds |
| ES2393814T3 (es) * | 2007-04-04 | 2012-12-28 | Sigmoid Pharma Limited | Una composición farmacéutica oral |
| PL2458992T3 (pl) * | 2009-07-30 | 2016-07-29 | Teva Pharma | Leczenie choroby Leśniowskiego-Crohna z użyciem lakwinimodu |
| WO2012006538A1 (en) * | 2010-07-09 | 2012-01-12 | Teva Pharmaceutical Industries Ltd. | Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof |
| EP2590653A4 (en) * | 2010-07-09 | 2014-01-01 | Teva Pharma | 5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-1,2-DIHYDROCHINOLINE-3-CARBOXAMIDE, SALT THEREOF AND APPLICATIONS THEREOF |
| WO2012050500A1 (en) | 2010-10-14 | 2012-04-19 | Lars Pettersson | 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators. |
| US9200046B2 (en) * | 2011-06-29 | 2015-12-01 | Cornell University | Reporter system for high throughput screening of compounds and uses thereof |
| GB202006390D0 (en) * | 2020-04-30 | 2020-06-17 | Aqilion Ab | Novel treatments |
-
2020
- 2020-04-30 GB GBGB2006390.5A patent/GB202006390D0/en not_active Ceased
-
2021
- 2021-04-30 EP EP21723216.4A patent/EP4142725A1/en active Pending
- 2021-04-30 EP EP21723215.6A patent/EP4142724A1/en active Pending
- 2021-04-30 CA CA3177000A patent/CA3177000A1/en active Pending
- 2021-04-30 WO PCT/EP2021/061464 patent/WO2021219881A1/en not_active Ceased
- 2021-04-30 CA CA3176994A patent/CA3176994A1/en active Pending
- 2021-04-30 KR KR1020227041920A patent/KR20230018386A/ko active Pending
- 2021-04-30 KR KR1020227041908A patent/KR20230024892A/ko active Pending
- 2021-04-30 US US17/922,043 patent/US20230167064A1/en active Pending
- 2021-04-30 CN CN202180044567.7A patent/CN115768429B/zh active Active
- 2021-04-30 JP JP2022566660A patent/JP7702427B2/ja active Active
- 2021-04-30 AU AU2021262514A patent/AU2021262514A1/en active Pending
- 2021-04-30 CN CN202180043624.XA patent/CN115916200A/zh active Pending
- 2021-04-30 JP JP2022566661A patent/JP2023524519A/ja active Pending
- 2021-04-30 AU AU2021266154A patent/AU2021266154A1/en active Pending
- 2021-04-30 WO PCT/EP2021/061462 patent/WO2021219879A1/en not_active Ceased
- 2021-04-30 GB GB2207709.3A patent/GB2605894B/en active Active
- 2021-04-30 US US17/922,072 patent/US20230202982A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023524519A5 (https=) | ||
| CN106573902B (zh) | 氨基烷基苯并硫氮杂*衍生物及其用途 | |
| CN103492361B (zh) | 取代的1-苄基环烷基羧酸及其用途 | |
| JP2024504932A5 (https=) | ||
| CN1040323C (zh) | 噻唑烷衍生物 | |
| ES2670571T3 (es) | Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis B | |
| JP2022534426A5 (https=) | ||
| RU2008127312A (ru) | Мезилатное пролекарство леводопы, его композиции и применение | |
| AR051248A1 (es) | Derivados de 3-arilamino piridina | |
| JP2005526011A5 (https=) | ||
| JP2008509953A5 (https=) | ||
| JP2013500304A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| RU2008119651A (ru) | Производные дикарбоновых кислот и их применение | |
| KR20120055571A (ko) | 종양성 또는 자가면역 질환 치료용 전구약물로서의 푸라자노벤즈이미다졸 | |
| RU2013120556A (ru) | 1,2-гидрокси-2-оксо-хинолин-3-карбоксанилиды в качестве активаторов ahr | |
| TW201538155A (zh) | 活性成份輔助組成物及將活性成份化合物遞送給對象之方法 | |
| FR2762315A1 (fr) | Derives d'amino-acides inhibiteurs des metalloproteases de la matrice extracellulaire et de la liberation du tnf alpha | |
| JP2011520931A (ja) | ｛ｆ−１９｝標識ｌ−グルタミン酸及びｌ−グルタミン誘導体（ｉｉｉ）、それらの使用並びにそれらを得る方法 | |
| JP7728260B6 (ja) | 発毛を促進する化合物の合成 | |
| JP2024507140A (ja) | 抗菌性化合物 | |
| JP2024502178A5 (https=) | ||
| WO2006043655A1 (ja) | 吸入用医薬組成物 | |
| JP7835403B2 (ja) | イタコネートおよびメチルイタコネートの新規プロドラッグ | |
| WO2006103274A8 (fr) | Inhibiteurs d'age |